A potential treatment of non-alcoholic fatty liver disease with SIRT1 activators.
Colak Y, Yesil A, Mutlu HH, Caklili OT, Ulasoglu C, Senates E, Takir M, Kostek O, Yilmaz Y, Yilmaz Enc F, Tasan G, Tuncer I.
Colak Y, et al. Among authors: yesil a.
J Gastrointestin Liver Dis. 2014 Sep;23(3):311-9. doi: 10.15403/jgld.2014.1121.233.yck.
J Gastrointestin Liver Dis. 2014.
PMID: 25267960
Free article.
Review.